Form 8-K - Current report:
SEC Accession No. 0001193125-25-184706
Filing Date
2025-08-21
Accepted
2025-08-21 08:33:01
Documents
14
Period of Report
2025-08-21
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d51455d8k.htm   iXBRL 8-K 23994
2 EX-99.1 d51455dex991.htm EX-99.1 12086
6 GRAPHIC g51455g0821065502215.jpg GRAPHIC 2431
  Complete submission text file 0001193125-25-184706.txt   158685

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sepn-20250821.xsd EX-101.SCH 2851
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE sepn-20250821_lab.xml EX-101.LAB 17976
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sepn-20250821_pre.xml EX-101.PRE 11258
16 EXTRACTED XBRL INSTANCE DOCUMENT d51455d8k_htm.xml XML 3635
Mailing Address 250 EAST GRAND AVENUE, SUITE 65 SOUTH SAN FRANCISCO CA 94080
Business Address 250 EAST GRAND AVENUE, SUITE 65 SOUTH SAN FRANCISCO CA 94080 650-338-3533
Septerna, Inc. (Filer) CIK: 0001984086 (see all company filings)

EIN.: 843891440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42382 | Film No.: 251238475
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)